Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3382-3387

  Sun, X ^a   Zhou, Z ^a   Kang, Y J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; METALLOTHIONEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; GENE OVEREXPRESSION; HEART HYPERTROPHY; HEART MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOMEGALY; DOXORUBICIN; HEART; MALE; METALLOTHIONEIN; MICE; MICE, TRANSGENIC; MICROSCOPY; MYOCARDIUM;

EID: 0035870265     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. The impact of induction anthracycline on long-term failure-free survival in childhood acute, lymphoblastic leukemia
2. Acute arrhythmogenicity of doxorubicin administration
3. Risk factors for doxorubicin-induced congestive heart failure
4. Overview of cardiac pathology in relation to anthracycline cardiotoxicity
5. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals
6. Cardiac toxicity 4 to 20 years after completing anthracycline therapy
7. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
8. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography
9. Early and delayed clinical cardiotoxicity of doxorubicin
10. Doxorubicin-induced cardiomyopathy
11. Adriamycin: The role of lipid peroxication in cardiac toxicity and tumor response
12. Metallothionein
13. Overview of metallothionein
14. Oxygen free radical and metallothionein
15. Possible role for metallothionein in protection against radiation-induced oxidative stress: Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals
16. Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage
17. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels
18. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity
19. Metallothionein inhibits ischemia-reperfusion injury in mouse heart
20. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart
21. Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein
22. 2 with sulfhydryl groups in HL-60 cells: Zinc-metallothionein and other sites
23. Metallothionein induction prevents toxic side effects of cisplatin and Adriamycin used in combination
24. Involvement of cardiac metallothionein in prevention of Adriamycin induced lipid peroxidation in the heart
25. Specific reduction of toxic side effects of Adriamycin by induction of metallothionein in mice
26. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases
27. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes
28. Quantitative experimental evaluation of Adriamycin cardiotoxicity in the mouse
29. Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay
30. Methods of reducing the cardiotoxicity of anthracyclines
31. Role of iron in Adriamycin biochemistry
32. The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane]: Its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of Adriamycin
33. Strategies for prevention of anthracycline cardiotoxicity
34. Dose-response relationship of dexrazoxane for prevention of doxornbicin-induced cardiotoxicity in mice, rats, and dogs
35. Toxicity profile of dexrazoxane (Zinecard, ICRF-187, ADR-529, NSC- 69780), a modulator of doxorubicin cardiotoxicity
36. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity
37. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation
38. Endothelial nitric oxide synthase-dependent superoxide generation from Adriamycin
39. Induction of antioxidants by Adriamycin in mouse heart
40. Thiolate ligands in metallothionein confer redox activity on zinc clusters
41. Coordination dynamics of biological zinc "clusters" in metallothioneins and in the DNA-binding domain of the transcription factor Ga14
42. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase
43. In vitro and in vivo studies on the degradation of metallothionein
44. The antioxidant function of metallothionein in the heart
45. Changes in myocardial metallothionein on isoproterenol-induced myocardial injury
46. Tissue specific induction of metallothionein synthesis by tumor necrosis factor-α